Journals / Southern Clinics of Istanbul Eurasia / 2022 / Cilt: 33 - Sayı: 1

Evaluation of Anxiety, Depression, and Insomnia Levels of Healthcare Professionals after Inactive COVID-19 Vaccination (CoronaVac)

Pages
9–15
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, after the start of the immunization process, the frequency of these mental disorders and the anxiety levels of the healthcare professionals significantly decreased.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:bjective: The aim of this study was to examine changes in the levels of depression, anxiety, and insomnia after inactive COVID-19 vaccination among healthcare professionals working actively during the COVID-19 pandemic.
📊
Key Findings & Data:Methods: This cross-sectional study was conducted from January 1, 2021, to June 30, 2021, using an online survey across frontline healthcare professionals in Turkey.
💡
Conclusion & Impact:However, after the start of the immunization process, the frequency of these mental disorders and the anxiety levels of the healthcare professionals significantly decreased.
🔬Design:Survey & Empirical Study
📍Scope:2021 Verileri
⚙️Variables:Domain Parameters

Abstract

bjective: The aim of this study was to examine changes in the levels of depression, anxiety, and insomnia after inactive COVID-19 vaccination among healthcare professionals working actively during the COVID-19 pandemic. Methods: This cross-sectional study was conducted from January 1, 2021, to June 30, 2021, using an online survey across frontline healthcare professionals in Turkey. The Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) scale were used to evaluate the mental health of the participants, and the Insomnia Severity Index-7 (ISI-7) was used to evaluate their sleep problems. The data obtained from two different periods, pre-vaccination and post-vaccination, were examined. Results: The study included 416 healthcare professionals. The frequency of depression, anxiety, and insomnia was 27.9%, 31.5%, and 41.1%, respectively, in the pre-vaccination period, and there was a decrease in these rates (22.8%, 21.9%, and 34.1%, respectively) in the post-vaccination period. The differences between the two periods were also statistically significant for the PHQ-9 (p=0.000), GAD-7 (p=0.002), and ISI-7 (p=0.038) scores. We determined that the presence of long weekly working hours, being female, living alone, and presence of psychiatric disease were effective in the development of depression and anxiety. Conclusion: Among frontline healthcare professionals, depression, anxiety, and insomnia symptoms and the frequency of the diagnosis of these clinical conditions increased due to the COVID-19 pandemic. However, after the start of the immunization process, the frequency of these mental disorders and the anxiety levels of the healthcare professionals significantly decreased.

🔖

Cite This Article

KOÇAK, A. O., AKBAŞ, İ., DOĞRUYOL, S., DEMİRHAN, R., TEKYOL, D., DOĞRUYOL, T., AVCI, S. (2022). Evaluation of Anxiety, Depression, and Insomnia Levels of Healthcare Professionals after Inactive COVID-19 Vaccination (CoronaVac). Southern Clinics of Istanbul Eurasia, Cilt: 33 - Sayı: 1, 9–15. https://ajindex.com/articles/592708

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol 2020;92:401
  2. WHO. Coronavirus disease (COVID-2019) situation reports. March 11, 2020. Available at: https://www.who.int/emergencies/ diseases/novel-coronavirus-2019/situation-reports. Accessed Apr 19, 2021
  3. Heaton PM. The Covid-19 vaccine-development multiverse. N Engl J Med 2020;383:1986–8
  4. Krammer F. SARS-CoV-2 vaccines in development. Nature 2020;586:516–27
  5. WHO. Draft landscape of Covid-19 candidate vaccines. March 26, 2021. Available at: https://www.who.int/blueprint/priority-diseases/key-action/novel coronavirus_landscape_ncov.pdf. Accessed Apr, 2021
  6. Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis 2021;21:181–92
  7. Gencturk A, Bir B. Turkey reports over 28,000 new coronavirus cases. Ankara: Anadolu Agency. March 3, 2021. Available at: https:// www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkey-reportsover-28-000-new-coronavirus-cases/2188507. Accessed Apr, 2021
  8. Khanna RC, Honavar SG, Metla AL, Bhattacharya A, Maulik PK. Psychological impact of COVID-19 on ophthalmologists-in-training and practising ophthalmologists in India. Indian J Ophthalmol 2020;68:994
  9. Buckley C, Wee S-L, Qin A. China’s doctors, fighting the coronavirus, beg for masks. Available at: https://www.nytimes.com/2020/02/14/ world/asia/china-coronavirus-doctors.html. Accessed Feb 25, 2022
  10. Bakan Koca: Sağlık çalışanları arasındaki vaka sayısı 12 bini geçti, 216’sı hayatını kaybetti. BBC Türkçe Dec 9, 2020. Available at: https://www.bbc.com/turkce/live/haberler-turkiye-55240692. Accessed Feb 25, 2022
  11. Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open 2020;3:e203976
  12. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282:1737–44
  13. Sari YE, Kokoglu B, Balcioglu H, Bilge U, Colak E, Unluoglu I. Turkish reliability of the patient health questionnaire-9. Biomed Res-India 2016;27:460–2
  14. Spitzer RL, Kroenke K, Williams JB, Lowe B